RESUMO
No disponible
Assuntos
Humanos , Masculino , Feminino , Idoso , Idoso de 80 Anos ou mais , Fibrilação Atrial/epidemiologia , Anticoagulantes/uso terapêutico , Hospitalização/estatística & dados numéricos , Estudos Prospectivos , Acidente Vascular Cerebral/induzido quimicamente , ComorbidadeRESUMO
Objetivos. Conocer la prevalencia del síndrome metabólico (SM) según las definiciones del National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III ) y la International Diabetes Federation (IDF) y su relación con la enfermedad cardiovascular (ECV) en los ancianos hospitalizados. Material y método. Estudio descriptivo, prospectivo realizado entre febrero y marzo del 2011. Se estudiaron 200 pacientes consecutivos hospitalizados. Se registraron las variables sociodemográficas, clínicas, bioquímicas y antecedentes personales. Resultados. La prevalencia del SM fue del 65% (NCEP-ATP III ) y 67,5% (IDF), siendo mayor en las mujeres (NCEP-ATP III = 72,8%; IDF = 73,6%), que en los varones (NCEP-ATP III = 50,7%; IDF = 56,3%). La edad media de los pacientes diagnosticados de SM según ambos criterios diagnósticos fue parecido: 84,7 años. El SM no se asoció a una mayor prevalencia de ECV. Conclusiones. El SM tiene una elevada prevalencia en los ancianos hospitalizados, siendo mayor en mujeres, tanto con los criterios NCEP-ATP III como con los de la IDF. En nuestra población el SM no se asoció a una mayor prevalencia de ECV (AU)
Objectives. To determine the prevalence of metabolic syndrome (MS) according to the definitions of the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) and the International Diabetes Federation (IDF) and its relation to cardiovascular disease (CVD) in hospitalized elderly patients. Material and methods. This descriptive and prospective study (February-March 2011) included 200 consecutive patients hospitalized in a Geriatric Department. Sociodemographic, clinical and biochemical data was collected. Results. The prevalence of MS was 65% (NCEP-ATP III) and 67.5% (IDF) and was greater in women (NCEP-ATP III=72.8%, IDF=73.6%) than in men (NCEP-ATP III=50.7%; IDF=56.3%). The mean age of patients diagnosed with MS by both diagnostic criteria were similar: 84.7 years. MS was not associated with an increased prevalence of CVD. Conclusions. MS is highly prevalent in elderly hospitalized patients, being higher in women, with both diagnostic criteria (NCEP- ATP III and IDF). In our population the MS was not associated with an increased prevalence of CVD (AU)
Assuntos
Humanos , Masculino , Feminino , Síndrome Metabólica/epidemiologia , Síndrome Metabólica/prevenção & controle , Pressão Arterial/fisiologia , Hiperlipidemias/epidemiologia , Hiperlipidemias/prevenção & controle , Estudos Prospectivos , Repertório de Barthel , Diabetes Mellitus/epidemiologia , Diabetes Mellitus/prevenção & controle , TriglicerídeosAssuntos
Fibrilação Atrial/epidemiologia , Pacientes Internados/estatística & dados numéricos , Idoso , Anticoagulantes/uso terapêutico , Fibrilação Atrial/tratamento farmacológico , Fármacos Cardiovasculares/uso terapêutico , Transtornos Cognitivos/epidemiologia , Comorbidade , Fibrinolíticos/uso terapêutico , Insuficiência Cardíaca/epidemiologia , Frequência Cardíaca/efeitos dos fármacos , Humanos , Seleção de Pacientes , Guias de Prática Clínica como Assunto , Prevalência , Estudos Prospectivos , Fatores de Risco , Espanha/epidemiologiaRESUMO
OBJECTIVES: To determine the prevalence of metabolic syndrome (MS) according to the definitions of the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) and the International Diabetes Federation (IDF) and its relation to cardiovascular disease (CVD) in hospitalized elderly patients. MATERIAL AND METHODS: This descriptive and prospective study (February-March 2011) included 200 consecutive patients hospitalized in a Geriatric Department. Sociodemographic, clinical and biochemical data was collected. RESULTS: The prevalence of MS was 65% (NCEP-ATP III) and 67.5% (IDF) and was greater in women (NCEP-ATP III=72.8%, IDF=73.6%) than in men (NCEP-ATP III=50.7%; IDF=56.3%). The mean age of patients diagnosed with MS by both diagnostic criteria were similar: 84.7 years. MS was not associated with an increased prevalence of CVD. CONCLUSIONS: MS is highly prevalent in elderly hospitalized patients, being higher in women, with both diagnostic criteria (NCEP- ATP III and IDF). In our population the MS was not associated with an increased prevalence of CVD.
